Zimmerman and colleagues examined how many depressed patients who scored in the remission range on the 17-item Hamilton Depression Rating Scale (HDRS) did not consider themselves to be in remission ...
MedPage Today on MSN
FDA Broadens Caplyta Approval to Include Major Depression
The FDA approved lumateperone (Caplyta) as an adjunctive therapy with antidepressants for the treatment of major depressive ...
PsyPost on MSN
“Major problem”: Ketamine fails to outperform placebo for treating severe depression in new clinical trial
A new clinical trial has found that adding repeated intravenous ketamine infusions to standard care for hospitalized patients ...
Researchers from Trinity College, St Patrick’s Mental Health Services, Queen’s University Belfast, Ireland, investigate use of twice-weekly ketamine infusions as an add-on treatment for inpatients wit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback